at WellDyneRx

I am the Link...

…between patient and doctor, making sure our members get the right medicine at the right price, so they can enjoy healthy lives.

Learn more about the WellDyneRx difference.

Read More
at WellDyneRx

I am the Link...

…to ensure that every prescription goes out to our health plan customer’s members, so they always have their meds on time.

Learn more about WellDyneRx’s resources and drug reports.

Read More
at WellDyneRx

I am the Link...

…between our proprietary technology platforms and the lower cost solutions and drug cost containment our clients enjoy.

Learn more about WellDyneRx’s flexible solutions.

Read More

Every Little Thing Brings BIG OUTCOMES

WellDyneRx is a full-service, independent Pharmacy Benefit Manager (PBM) that makes the little things matter for our clients, employees, partners, and members.

Because we are an independent PBM—meaning we are not owned by a pharmacy, drug company, or health insurance provider—we are able to negotiate freely on your behalf to keep costs low and quality of care high for our clients and members.

As early pioneers in clinical pharmacy, WellDyneRx has a history of caring for patients differently and always from a pharmacological perspective. We don’t just fill prescriptions. We constantly manage and optimize our formulary to match members with treatments that are effective and economical.

Most of all, our clients value the flexibility and customization they get with WellDyneRx. Whatever you need, we can create the right plan for you. Custom solutions for maximum flexibility, because everything we do on your behalf adds up for our clients and members. Every little thing brings big outcomes.

Accreditations

WellDyneRx Selected to Provide Pharmacy Services for DaVita’s Medicare Part B Bundled Program

WellDyneRx, a full-service, independent Pharmacy Benefit Manager (PBM), entered into an agreement with DaVita Inc. to take over their Medicare Part B Bundled Program. WellDyneRx dispensed their first prescriptions to DaVita patients in November 2018 after a successful transition period.